🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Double-blind, Randomized, Active-controlled, Phase 3 Study ...
Status
Completed
Location
Center For Clinical And Basic Research
Start Date
2021-06-17
Trial ID
NCT04757376
Treatments Being Tested
This study is to compare PK, PD, safety, tolerability, and immunogenicity p...
Status
Completed
Location
Biotrial
Start Date
2020-10-19
Trial ID
NCT04621318
Treatments Being Tested
This is a randomized, double-blind, parallel design, repeat dose, 2 arm, mu...
Status
Completed
Location
Investigational Site 3501
Start Date
2022-08-23
Trial ID
NCT05395091
Randomized, double blind, parallel group, single dose, 3 arm study to inves...
Status
Completed
Location
Biokinetica - Early Phase Institute
Start Date
2022-03-01
Trial ID
NCT05299073
Treatments Being Tested
Part I of the study： This is a randomised, single-dose, subcutaneous inject...
Status
Completed
Location
Huashan Hospital，Fudan University
Start Date
2020-11-03
Trial ID
NCT04534582
Treatments Being Tested
This trial is a randomized, double-blind, three-arm, parallel-group, pharma...
Status
Completed
Location
Parexel International GmbH, Early Phase Clinical Unit Berlin
Start Date
2021-03-09
Trial ID
NCT06095427
Treatments Being Tested
A Randomized, Double-blind, Two-arm, Parallel group, Single-dose, Phase I S...
Status
Completed
Location
CHA Bundang Medical Center
Start Date
2021-10-06
Trial ID
NCT06037395
Treatments Being Tested
The primary objective of this study is to demonstrate equivalent efficacy o...
Status
Completed
Location
Diagnostic Consultative Center Aleksandrovska
Start Date
2021-06-16
Trial ID
NCT04934072
Treatments Being Tested
This study has been designed as a randomized, double-blind, parallel-group ...
Status
Completed
Location
Biokinetica
Start Date
2023-07-21
Trial ID
NCT05876949
A Randomized, Double-blind, Controlled, Parallel-group, Single Dose, Three-...
Status
Completed
Location
Xentria Investigative Site
Start Date
2024-06-05
Trial ID
NCT06310824
Treatments Being Tested